Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.176,59
-0,88%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Prelude Therapeutics Inc (PRLD) Prelude Therapeutics Inc (PRLD) Notizie

Prelude Therapeutics Inc

PRLD
4,07
0,03 (0,74%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/4/202422:35GLOBEPrelude Highlights Continued Strength of Discovery Engine at..
05/3/202422:45GLOBEPrelude Announces Acceptance of Multiple Preclinical..
05/3/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:05GLOBEPrelude Therapeutics to Participate in Barclays Global..
15/2/202423:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:22EDGAR2Form 8-K - Current report
15/2/202422:05GLOBEPrelude Therapeutics Reports Full Year 2023 Financial..
12/2/202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:34GLOBEPrelude Therapeutics Announces $25 Million Private Placement
11/12/202315:17EDGAR2Form 8-K - Current report
01/11/202321:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:23EDGAR2Form 8-K - Current report
01/11/202321:10GLOBEPrelude Announces Strategic Pipeline Progress and Updates,..
01/11/202321:05GLOBEPrelude Therapeutics and AbCellera Enter Partnership to..
14/10/202318:30GLOBEPrelude Announces Multiple Clinical and Preclinical Poster..
06/10/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202314:30GLOBEPrelude Therapeutics to Participate in Three Healthcare..
03/8/202314:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:10EDGAR2Form 8-K - Current report
03/8/202314:00GLOBEPrelude Therapeutics Announces Second Quarter 2023 Financial..
06/7/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202314:30GLOBEPrelude Therapeutics To Participate in Jefferies Healthcare..
18/5/202313:00GLOBEPrelude Therapeutics Announces Pricing of Public Offering
17/5/202322:08GLOBEPrelude Therapeutics Announces Launch of Proposed Public..
08/5/202314:30GLOBEPrelude Therapeutics Announces First Quarter 2023 Financial..
Apertura: 4,04 Min: 3,99 Max: 4,07
Chiusura: 4,04

La tua Cronologia

NASDAQ
PRLD
Prelude Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network